期刊文献+

抗生素、非甾体类消炎药及α-受体阻滞剂等综合治疗Ⅲ型前列腺炎 被引量:6

Comprehensive therapy of chronic prostatitis/chronic pelvic pain syndrome with antibiotics,anti-inflammatory and α-blockers
下载PDF
导出
摘要 目的:探讨采用抗生素、非甾体类消炎药及α-受体阻滞剂等综合方案对慢性Ⅲ型前列腺炎患者的诊治。方法:CP/CPPS前列腺炎患者184例,采取抗生素、非甾体类消炎药及α-受体阻滞剂等综合治疗,治疗第6月采用前列腺炎症状评分(CPSI)标准判定疗效。结果:治疗第6月治疗前后CPSI评分中的疼痛(8.9至5.1)、生活质量(7.6至3.5)、排尿症状(5.4至2.5)及总分(21.7至12.3)均有显著性改善(P<0.05)。第6月的临床总有效率为76.5%,而采取单一方法临床有效的患者为10例(6.4%),两者间有统计学差异(P<0.05)。结论:综合使用抗生素、非甾体类消炎药物及α-受体阻滞剂等可有效缓解难治性CP/CPPS患者症状。 Objective:To investigate the efficacy of multimodal therapy of chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS) with antibiotics,anti-inflammatory,α-blockers and etc.Methods: A total of 154 CP/CPPS patients were treated with antibiotics,anti-inflammatory,α-blockers and etc.The therapeutic efficacy was evaluated by using the chronic prostatitis symptom index(CPSI) after 6-month treatment.Results: The scores of total CPSI,pain,quality of life and voiding before and after 6-month treatment were 21.7 vs.12.3,8.9 vs.5.1,7.6 vs.3.5 and 5.4 vs.2.5,respectively(P<0.05).The total effective rates of comprehensive therapy and single treatment method were 76.5% and 6.4%(P<0.05).Conclusion: The multimodal therapy with antibiotics,anti-inflammatory and α-blockers can be effective for patients with CP/CPPS.
作者 肖庆 王尉
出处 《西北国防医学杂志》 CAS 2010年第4期253-254,共2页 Medical Journal of National Defending Forces in Northwest China
基金 卫生部笹川医学奖学金同学会科研启动基金资助项目(2009-117)
关键词 前列腺炎 骨盆疼痛 治疗 抗生素 Prostatitis Pelvic pain Therapy Antibiotics
  • 相关文献

参考文献6

二级参考文献54

  • 1胡瑜,商学军,李宏军,胡毓安,邵永,黄宇烽.慢性前列腺炎对血清PSA水平的影响[J].中华男科学杂志,2004,10(12):907-908. 被引量:12
  • 2Nickel JC. Downey J. Johnston B, et al. Predictors of patient response to antibiotic therapy for the chronic prostatitis/ chronic prostatitis symptom: A prospective multicenter clinical trial. J Urol, 2001, 165(5): 1539 - 1544.
  • 3Litwin MS, McNaughton CM ,Fowler FJ Jr,et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol, 1999,162(2): 369 - 375.
  • 4Nickel JC, Nigro M, Valiquette L, et al. Diagnosis and treatment of prostatitis in Canada. Urology, 1998,52(5): 797 - 802.
  • 5Krieger JN, Nyberg LM, Nickel JC. NIH consensus definition and classification of prostatitis. JA MA , 1999 , 282 (3) : 236 - 237.
  • 6True LD, Berger RE, Rothman I, et al. Prostate histopathology and the chronic prustatitis/chronic pelvic pain syndrome: a prospective biopsystudy. J Urul, 1999,162(6): 2014 - 2018.
  • 7Schaeffer AJ, Knauss JS, Landis JR, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol,2002,168 (3): 1048 - 53.
  • 8Nickel JC, Alexander RB, Schaeffer A J, et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol,2003,170(3 ): 818 - 822.
  • 9Schaeffer AJ. Classification (traditional and National Institutes of Health) and demographics of prostatitis. Urology,2002, (6 Suppl): 5 -6.
  • 10Krieger JN,Riley DE. Bacteria in the chronic prostatitis-chronic pelvic pain syndrome: molecular approaches to critical research questions. J Urol, 2002,167 (6) : 2574 - 2583.

共引文献38

同被引文献59

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部